Wall Street brokerages expect National Research Co. (NASDAQ:NRCIB) to post $0.23 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for National Research’s earnings. National Research posted earnings per share of $0.18 in the same quarter last year, which would indicate a positive year-over-year growth rate of 27.8%. The company is scheduled to announce its next earnings results on Tuesday, August 1st.
On average, analysts expect that National Research will report full-year earnings of $0.98 per share for the current financial year. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover National Research.
National Research (NASDAQ:NRCIB) last announced its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.26 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by $0.55. The business had revenue of $30.28 million during the quarter. National Research had a net margin of 18.99% and a return on equity of 35.36%.
A number of equities research analysts have recently weighed in on NRCIB shares. Zacks Investment Research cut National Research from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 19th. First Analysis cut National Research from an “overweight” rating to an “equal weight” rating and set a $44.00 price objective for the company. in a research note on Thursday, February 16th.
Shares of National Research (NASDAQ:NRCIB) traded up 0.000% during trading on Thursday, reaching $47.145. The company’s stock had a trading volume of 51 shares. The company has a market capitalization of $1.14 billion, a PE ratio of 54.440 and a beta of 0.33. National Research has a 1-year low of $32.18 and a 1-year high of $49.29. The stock has a 50 day moving average of $44.12 and a 200-day moving average of $41.22.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 14th. Stockholders of record on Friday, June 30th will be paid a $0.60 dividend. The ex-dividend date is Wednesday, June 28th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 5.09%. National Research’s payout ratio is presently 500.00%.
TRADEMARK VIOLATION NOTICE: This story was first published by sleekmoney and is the property of of sleekmoney. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at https://sleekmoney.com/zacks-brokerages-expect-national-research-co-nrcib-to-announce-0-23-eps/1892758.html.
Several large investors have recently modified their holdings of NRCIB. Tudor Investment Corp Et Al bought a new position in National Research during the fourth quarter valued at approximately $213,000. Willis Investment Counsel boosted its position in National Research by 6.7% in the fourth quarter. Willis Investment Counsel now owns 29,609 shares of the business services provider’s stock valued at $1,234,000 after buying an additional 1,855 shares during the last quarter. WCM Investment Management CA boosted its position in National Research by 1.2% in the first quarter. WCM Investment Management CA now owns 50,863 shares of the business services provider’s stock valued at $1,996,000 after buying an additional 610 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in National Research by 0.5% in the first quarter. Dimensional Fund Advisors LP now owns 90,616 shares of the business services provider’s stock valued at $3,570,000 after buying an additional 457 shares during the last quarter. Finally, Rice Hall James & Associates LLC boosted its position in National Research by 2.9% in the first quarter. Rice Hall James & Associates LLC now owns 9,998 shares of the business services provider’s stock valued at $392,000 after buying an additional 284 shares during the last quarter. 2.52% of the stock is owned by institutional investors and hedge funds.
National Research Co is a business services company in the Health Care Services industry.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/zacks-brokerages-expect-national-research-co-nrcib-to-announce-0-23-eps/1892758.html
Receive News & Ratings for National Research Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Co. and related companies with MarketBeat.com's FREE daily email newsletter.